ImmunoCellular Therapeutics's total assets for Q2 2018 were $3.83M, a decrease of -25.85% from the previous quarter. IMUC total liabilities were $401.94K for the fiscal quarter, a -73.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.